STAT

How Europe is building a sweeping system to study medication safety in pregnant and lactating women

More than 88 organizations have joined a sweeping new effort in Europe to tackle the research gaps on medication use in pregnant and lactating women.
Source: FRED DUFOUR/AFP/Getty Images

Drug companies, politicians, hospitals, doctors, and patients all agree that there isn’t nearly enough information about whether a given medicine is safe for pregnant and breastfeeding women to use or whether it will work.

A sweeping new effort in Europe aims to change that by bringing all of those groups together to address a public health issue they say demands urgent attention.

The project, dubbed ConcePTION, is a $32 million effort from the Innovative Medicines Initiative, a public-private partnership between the drug industry and the European Commission, the executive branch of the European Union. There are more than 200 researchers and 88 organizations involved in ConcePTION, which is being

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readPolitics
Biden Cancer Initiative To Suspend Operations As 2020 Campaign Heats Up
The Biden Cancer Initiative, the nonprofit former Vice President Joe Biden started two years ago after leaving the White House, is shutting down, at least for now.
STAT4 min read
Opinion: Opioid Overdose Should Be Treated Like Attempted Suicide: With An Emergency Hold
Having first responders provide a dose of buprenorphine after an overdose rescue is like having them provide Prozac to someone they just pulled from the ledge of a 20-story building…
STAT3 min readSociety
Christi Shaw, Inspired By Her Sister’s Cancer, Named CEO Of Kite Pharma, Gilead’s Anti-cancer Unit
Christi Shaw, an Eli Lilly executive, has been named the new head of Kite Pharma, which is focused on treatments that genetically engineer patients’ white blood cells to attack cancer.